Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1968 2
1970 1
1971 1
1976 1
1977 3
1979 3
1980 1
1981 8
1982 4
1983 2
1984 3
1985 5
1986 5
1987 4
1988 12
1989 7
1990 7
1991 5
1992 3
1993 8
1994 7
1995 3
1996 13
1997 14
1998 16
1999 11
2000 16
2001 13
2002 19
2003 26
2004 13
2005 14
2006 15
2007 21
2008 15
2009 27
2010 28
2011 24
2012 40
2013 50
2014 33
2015 31
2016 57
2017 43
2018 49
2019 58
2020 75
2021 97
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

827 results
Results by year
Filters applied: . Clear all
Page 1
The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support.
Irmisch A, Bonilla X, Chevrier S, Lehmann KV, Singer F, Toussaint NC, Esposito C, Mena J, Milani ES, Casanova R, Stekhoven DJ, Wegmann R, Jacob F, Sobottka B, Goetze S, Kuipers J, Sarabia Del Castillo J, Prummer M, Tuncel MA, Menzel U, Jacobs A, Engler S, Sivapatham S, Frei AL, Gut G, Ficek J, Miglino N; Tumor Profiler Consortium, Aebersold R, Bacac M, Beerenwinkel N, Beisel C, Bodenmiller B, Dummer R, Heinzelmann-Schwarz V, Koelzer VH, Manz MG, Moch H, Pelkmans L, Snijder B, Theocharides APA, Tolnay M, Wicki A, Wollscheid B, Rätsch G, Levesque MP. Irmisch A, et al. Among authors: esposito c. Cancer Cell. 2021 Mar 8;39(3):288-293. doi: 10.1016/j.ccell.2021.01.004. Epub 2021 Jan 21. Cancer Cell. 2021. PMID: 33482122
VEGF as a potential target in lung cancer.
Frezzetti D, Gallo M, Maiello MR, D'Alessio A, Esposito C, Chicchinelli N, Normanno N, De Luca A. Frezzetti D, et al. Among authors: esposito c. Expert Opin Ther Targets. 2017 Oct;21(10):959-966. doi: 10.1080/14728222.2017.1371137. Epub 2017 Aug 30. Expert Opin Ther Targets. 2017. PMID: 28831824 Review.
Roxadustat for the Maintenance Treatment of Anemia in Patients with End-Stage Kidney Disease on Stable Dialysis: A European Phase 3, Randomized, Open-Label, Active-Controlled Study (PYRENEES).
Csiky B, Schömig M, Esposito C, Barratt J, Reusch M, Valluri U, Sulowicz W. Csiky B, et al. Among authors: esposito c. Adv Ther. 2021 Oct;38(10):5361-5380. doi: 10.1007/s12325-021-01904-6. Epub 2021 Sep 19. Adv Ther. 2021. PMID: 34537926 Free PMC article. Clinical Trial.
Advances in mRNA non-viral delivery approaches.
Ibba ML, Ciccone G, Esposito CL, Catuogno S, Giangrande PH. Ibba ML, et al. Among authors: esposito cl. Adv Drug Deliv Rev. 2021 Oct;177:113930. doi: 10.1016/j.addr.2021.113930. Epub 2021 Aug 14. Adv Drug Deliv Rev. 2021. PMID: 34403751 Review.
Atherosclerotic-nephropathy: an updated narrative review.
Simeoni M, Borrelli S, Garofalo C, Fuiano G, Esposito C, Comi A, Provenzano M. Simeoni M, et al. Among authors: esposito c. J Nephrol. 2021 Feb;34(1):125-136. doi: 10.1007/s40620-020-00733-0. Epub 2020 Apr 8. J Nephrol. 2021. PMID: 32270411 Review.
Nucleic acids delivering nucleic acids.
Catuogno S, Esposito CL, Condorelli G, de Franciscis V. Catuogno S, et al. Among authors: esposito cl. Adv Drug Deliv Rev. 2018 Sep;134:79-93. doi: 10.1016/j.addr.2018.04.006. Epub 2018 Apr 6. Adv Drug Deliv Rev. 2018. PMID: 29630917 Review.
827 results